headquart brisban ca inc
innov focus leader market
comprehens product portfolio address
forecast exhibit compound-annual-growth-rate
reason report
initi coverag
potenti enhanc posit momentum alreadi establish
skew favor discretionari capit sale on-going model
risk associ on-going total makeov result
complet transform underway transform continu
demonstr posit oper result alreadi yield
consecut quarter double-digit revenu growth would
share modest expect corpor growth
estim million assum increas
sale partial off-set on-going invest infrastructur
oper synergi realiz specif model assum
import disclosur analyst certif page report access current disclosur
stephen inc cover compani client may refer
innovation-focus leader aesthet
energi system top-tier growth
margin profil valu rel
discount med tech industri peer
float share
note dollar million except per share data volum data thousand
set stage busi look
procedur
energy-bas cosmet procedur account
approxim total
bodi sculpt women
ultrasound laser light radiofrequ
treatment skin tighten wrinkl
women
microdermabras women
laser hair remov women
inject wrinkle-relax women
aesthet industri repres attract end market character larg exist end market
exhibit growth good bad econom time privat pay busi model devoid
reimburs risk appeal one largest popul demograph segment
asap isap compani report
compound-annual-growth-rate
found develop first hair remov
avail unit state past year compani
continu innov within energy-bas aesthet devic
last
cutr new manag team robust product pipelin on-going
oper improv posit compani outperform peer
within competit landscap laden corpor integr
grow approx compound-annual-growth-rate
asap compani document stephen inc
compani document stephen inc
xio reportedli look
sell lumeni bil
accord bloomberg
market realiz bil total
acquisit
dollar million
believ zeltiq cynosur repres
relev recent peer transact multipl
note transact multipl
correspond valuat impli xio
group bil price lumeni assum
revenu compound-annual-growth-rate sinc previou
transact octob
note syneron transact omit transact multipl
analysi compani annual revenu growth rate prior syneron
acquisit compar peer
dollar thousand
consolid aesthet energy-bas system
market serv creat disrupt marketplac
acquir compani undergo corpor integr
chang salesforc
uniqu
posit benefit industri pure-play
compani document stephen inc
appoint presid ceo member board januari
previous serv ceo drawbridg health inc co-ventur ge ventur
serv ceo aptu endosystem compani acquir
serv chief commerci offic cyberon
began career work year
previous serv chief offic tria beauti inc
serv chief offic vermillion lipid scienc well three addit privat compani
began career advanc cardiovascular system
previous serv head north american sale cynosur work year
serv vice-president
founder femtoblanc inc
led team sever mid-stag medic compani includ lensx newport corpor intrales
c-suit
benefit enhanc
direct heighten
board director
revenu
dollar million
quadrupl
end
cutr set goal tripl revenu base quadrupl stock price cours next five
year gain share within exist market diversifi top line balanc capit consumable/servic mix
drive oper effici success could trade approxim discount rel prevail peer
multipl still achiev compani share price appreci object
compani document stephen inc
mount consum interest aesthet procedur support obtain long-term goal
percent consum consid cosmet medic procedur doubl
last five year nearli consid cosmet treatment
dermatologist remain lead influenc consum decis undergo
aesthet procedur
ultrasound laser light
radiofrequ treatment skin
tighten wrinkl
cutr industry-lead offer address top non-
invas aesthet procedur consum interest
pursu
american societi dermatolog surgeri googl inc stephen inc
total makeov packag uniqu rel major med tech concern compar scale
growth prospect compani solidli profit basi earn forecast exhibit
compound-annual-growth-rate debt free million cash balanc sheet one
fastest organ growth stori revenu growth excess potenti oper
margin effect tripl due favor mix shift realiz oper effici
favor corpor transform undergo complet corpor transform upon assum
helm januari ceo reinstein revamp c-suit in-licens new technolog provid immedi access
emerg growth market implement myriad initi enhanc oper effici drive sustain
growth effect cultur chang permeat facet compani
robust cadenc industry-lead new devic technolog slate introduc new product one
hands-fre enhanc rapidli grow trusculpt platform lower-cost version
compani industry-lead laser design commerci outsid unit state addit
compani earli stage commerci recent in-licens technolog platform juliet secret rf
provid access rapidli grow women health vagin laxiti sexual function wrinkl scar
sheet million nol favor cash flow gener possess financi latitud pursu
target strategi diversifi portfolio opportun may aris
estim place compani amongst fastest grow concern yet share valu
approxim discount peer addit share also valu notabl discount recent
estimate organ compound-annual-growth-rate vs peer averag
op margin forecast effect doubl
estimate organ compound-annual-growth-rate vs peer averag
note dollar million
compani report stephen inc
appoint execut vice presid chief
offic decemb
global servic michael karav ph appoint
februari miguel parado resign role exec vice-president
jerri widman retir board
novemb elisha wade finney appoint board
director
increas servic contract implement system sale
current
increas system util
diversifi top line model assum domest unit sale
unit servic contract increas
new system sale
identifi market technolog associ per use
consum ultim transit revenu mix
balanc split capit versu consum
servic versu
continu increas sale forc product averag rep
product increas million million
invest graduat excel
inventori procur manag manufactur
process improv increas effici reduct
effort coupl exist
oper initi stand
enhanc lt sustain
growth margin stori
compani report stephen inc
robust cadenc industry-lead new devic technolog
juliet address market
vagin laxiti affect
design use treat
fine line wrinkl scar
lower price point version
hand free version
expect acceler
domest non-
cutr new product address combin billion exist market
opportun forecast grow
impress histori consist
consecut year organ revenu growth
consecut quarter consensu revenu growth
consecut quarter double-digit annual revenu growth
debt-fre balanc sheet mil nol gener cash
note dollar million except share price data
assum valu in-
line median
ev/rev multipl top
valu averag
zeltiq cynosur
two
valu compani
discount peer
achiev object
see page
note dollar million except share price data
stephen inc
stephen inc
dollar million
sale
oper
invest work capit
free
less pv
impli multipl final period
multipl final period cf
note dollar million
 market laser energi base devic character low barrier entri rel mani med tech end
market relat devic gener requir rather rigor pma pathway regulatori approv
approv commonli use number label indic practition
 accordingli compani abil obtain durabl competit clinic advantag via product differenti best
limit success effort cultiv new indic use like beset multipl fast follow
 cutr devic servic address larg discretionari consum end market accordingli relat market growth
highli depend upon consum interest accept aesthet procedur also abil pay
aforement pocket relat procedur reimburs insur
 assur consum continu pursu elect procedur suffici dispos
incom pursu aesthet procedur averag cost excess
 throughout market laser energi base aesthet devic underw materi wave
consolid total compani acquir total valu billion
 result competit landscap character larger diversifi medic devic concern
greater access capit resourc well number emerg entrant limit commerci
 current midst materi corpor transform liter transcend facet busi
remain unabash propon transform well underway yield notabl gain
must acknowledg potenti tempor disrupt oper stem on-going implement
restructur initi chang personnel
 cutr futur success highli depend time success obtain regulatori approv
plan new devic also expand indic use assur compani abl
continu obtain requisit approv ensur favor cadenc new product marketplac
 industri also character high level litig associ alleg patent infring royalti
licens disput medic liabil may becom subject litig divert
corpor focu resourc oper activ addit subject compani potenti monetari
top-tier organ growth margin expans stori
robust plan new product cadenc stand
enabl enhanc prevail rate growth
corpor transform stand materi enhanc
margin profil also recur natur
top line confid track-record execut
team execut plan
opportun capit cash rich balanc sheet
favor cash flow gener pursu new
indic diversifi portfolio
attract pure play lead fda clear
technolog highly-attract billion domest
trade
revenu valu discount compar
pure-play aesthet enter later-stag growth
entrench competit broad aesthet bundl
creat strateg advantag incumb
barrier entri wild west claim
util environ limit cutr abil fulli
disrupt system implement employe
transit process evolv
left behind
everi share
stand sell
increment system
equival million
american colleg obstetr gynecolog acog asap im health kaiser famili foundat stephen estim
domest market aesthet energy-bas procedur conserv
forecast exhibit compound-annual-growth-rate reach approxim
led estim compound-annual-growth-rate non-invas fat
reduct procedur estim compound-annual-growth-rate tattoo removal/skin
asap stephen inc
individu open elect surgeri
total open elect surgeri femal
household household incom
individu open elect surgeri
total open elect surgeri male
household household incom
increment individu open elect surgeri
consum interest
overal accept non-
penetr gain
increas
 censu data nlrbi asap stephen inc
averag bodi sculpt procedur cost
procedur cost rang
bodi sculpt among top aesthet procedur
consid unit state
unlik invas altern energy-bas
bodi sculpt procedur requir recoveri time
area bodi may treat energy-
base bodi sculpt procedur includ neck upper
arm waist thigh buttock
chin thigh abdomen
flank individu
less
treatment
indic non-invas lipolysi
abdomen achiev disrupt
adipocyt cell intend non-
invas aesthet use achiev
treatment
reduct abdomin
treatment
circumfer abdomen
treatment
expect grow
annual next year
asap compani document stephen inc estim
estim domest market non-invas bodi sculpt procedur exhibit
compound-annual-growth-rate procedur growth result billion market opportun
asap compani document stephen inc
googl trend indic search trusculpt outpac search
coolscuplt recent month would expect interest term
experi season exhibit coolsculpt last year
googl inc stephen inc
approxim domest adult popul
one tattoo
major get first tattoo age
tattoo regret yet less
bruis edema
time averag remov requir session
day treatment
expens averag cost per session impli
total cost patient
risk incomplet remov last ink
difficult remov approxim
chanc ink complet remov
gener popul tattoo
harri poll skin renew cosmet tattoo australia
defin tam
 least tatttoo
 popul least tattoo
tattoo popul regret
 tattoo popul regret
penetr tam
treatment
treatment
total cost remov
modest convers tattoo regret actual procedur yield sizabl
harri poll stephen inc
remov treatment
acn scar wrinkl
treatment
indic tattoo
treatment
indic remov
treatment
dark color tattoo ink
treatment benign pigment
treatment
treatment depend
skin tone color tattoo
asap compani document stephen inc estim
treatment
treatment
pigment lesion hair
treatment
skin resurfac
treatment
treatment
treatment depend
treatment area sever
case
asap compani document stephen inc estim
revenu growth
top-lin growth stand benefit
continu
growth instal base combin
increas dispos sale increas
longer term model increas servic contract
revenu approxim
million
conserv model flat product gross margin
despit expect favor mix shift favor
trusculpt due expect invest
inventori system well manufactur process
expect growth licens secret rf
acknowledg potenti gross margin
expand consum increas percentag
product revenu
million
million
invest
year leverag associ top-lin growth
off-set invest system sale
system instal sale forc product
continu ramp model assum oper profit
doubl next three year potenti
greater leverag realiz synergi realiz
earlier forecast
forecast earn compound-annual-growth-rate period
importantli note cutr earn reflect
conserv present
skin largest organ bodi
compris approxim
bodi mass weight
skin serv protect bodi
stress
mechan
function relat
thermoregul metabol synthesi
layer skin
epidermi outermost layer protect underli tissu infect dehydr chemic
radiat mechan stress layer also respons synthesi vitamin
hormon vitamin perform function relat thermoregul
dermi layer tough connect tissu compris primarili collagen ellastin give
skin elast structur includ sweat gland hair follicl somatosensori receptor
hypodermi subcutan layer primarili consist connect tissu fat serv connect
dermi muscl bone layer insul bodi help retain heat also serv
store energi reserv fat cell provid pad particularli around high contact area
palm hand sole feet buttock
period
period
period
total cost revenu
sale market
research develop
gener administr
loss incom oper
interest incom net
loss incom incom tax
provis benefit incom tax
sale market
research develop
gener administr
sale market
research develop
gener administr
ourc compani report tephen inc estim
note dollar million except per share data
period
period
period
period
total cost revenu
sale market
research develop
gener administr
loss incom oper
interest incom net
loss incom incom tax
provis benefit incom tax
ourc compani report tephen inc estim
note dollar million except per share data
revenu product categori
period
period
period
ourc compani report tephen inc estim
note dollar million except per share data
period
period
period
cash equival
cash equival market invest
properti equip net
defer revenu net current portion
accumul comprehens incom loss
total liabil stockhold equiti
ourc compani report tephen inc estim
note dollar million except per share data
period
period
period
tax benefit deficit stock-bas compens
excess tax benefit relat stock-bas compens
depreci amort
impair intang asset
adjust net loss incom
current asset prepaid expens
chang asset liabil
net cash use provid oper activ
acquisit properti equip softwar
acquisit intang asset
dispos properti equip
net chang market invest
proce sale market invest
proce matur market invest
purchas market invest
net cash provid use invest activ
repurchas common stock
proce exercis stock option
proce exercis stock option
tax paid relat equiti award
payment capit leas oblig
excess tax benefit relat stock-bas compens
net cash provid use financ activ
net increas decreas cash cash equival
cash equival begin period
cash equival end period
